DiaVize s.r.o.

Prague 140 00

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Diseases, Chronic Kidney Disease, Obesity, Overweight, Overweight or Obesity, Type 2 Diabetes

Studies at this site

• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease — Recruiting now
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed